Costs and benefits of diagnosing familial breast cancerHEIMDAL, K; MAEHLE, L; MØLLER, P et al.Disease markers. 1999, Vol 15, Num 1-3, pp 167-173, issn 0278-0240Article

Genetic epidemiology of BRCA1 mutations in NorwayMØLLER, P; HEIMDAL, K; APOLD, J et al.European journal of cancer (1990). 2001, Vol 37, Num 18, pp 2428-2434, issn 0959-8049Article

Altered p53 gene structure and expression in human epithelial cells after exposure to nickelMAEHLE, L; MATCALF, R. A; RYBERG, D et al.Cancer research (Baltimore). 1992, Vol 52, Num 1, pp 218-221, issn 0008-5472Article

BRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutationsBORG, A; DØRUM, A; HEIMDAL, K et al.Disease markers. 1999, Vol 15, Num 1-3, pp 79-84, issn 0278-0240Article

The Norwegian founder mutations in BRCA1: high penetrance confirmed in an incident cancer series and differences observed in the risk of ovarian cancerHEIMDAL, K; MAEHLE, L; APOLD, J et al.European journal of cancer (1990). 2003, Vol 39, Num 15, pp 2205-2213, issn 0959-8049, 9 p.Article

Effects of n-3 fatty acids during neoplastic progression and comparison of in vitro and in vivo sensitivity of two human tumour cell linesMAEHLE, L; EILERTSEN, E; MOLLERUP, S et al.British journal of cancer. 1995, Vol 71, Num 4, pp 691-696, issn 0007-0920Article

Risk reducing mastectomy : outcomes in 10 European centresEVANS, D. G. R; BAILDAM, A. D; MOLLER, P et al.Journal of medical genetics. 2009, Vol 46, Num 4, pp 254-258, issn 0022-2593, 5 p.Article

Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancersEVANS, D. G; GAARENSTROOM, K. N; VASEN, H. F. A et al.Journal of medical genetics. 2009, Vol 46, Num 9, pp 593-597, issn 0022-2593, 5 p.Article

Efficacy of early diagnosis and treatment in women with a family history of breast cancerMØLLER, P; REIS, M. M; PREECE, P et al.Disease markers. 1999, Vol 15, Num 1-3, pp 179-186, issn 0278-0240Article

Age-specific incidence rates for breast cancer in carriers of BRCA1 mutations from NorwayMØLLER, P; MAEHLE, L; VABØ, A et al.Clinical genetics. 2013, Vol 83, Num 1, pp 88-91, issn 0009-9163, 4 p.Article

Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT studyMITRA, Anita V; BANCROFT, Elizabeth K; EVANS, D. G et al.BJU international (Papier). 2011, Vol 107, Num 1, pp 28-39, issn 1464-4096, 12 p.Article

The BRCA1 syndrome and other inherited breast or breast-ovarian cancers in a Norwegian prospective seriesMØLLER, P; BORG, A; HEIMDAL, K et al.European journal of cancer (1990). 2001, Vol 37, Num 8, pp 1027-1032, issn 0959-8049Article

Growth of human lung adenocarcinoma in nude mice is influenced by various types of dietary fat and vitamin EMAEHLE, L; LYSTAD, E; EILERTSEN, E et al.Anticancer research. 1999, Vol 19, Num 3A, pp 1649-1655, issn 0250-7005Article

A BRCA1 founder mutation, identified with haplotype analysis, allowing genotype/phenotype determination and predictive testingDØRUM, A; MØLLER, P; VAN DER MEULEN, M. A et al.European journal of cancer (1990). 1997, Vol 33, Num 14, pp 2390-2392, issn 0959-8049Article